Saturday, October 25, 2014 5:58:51 AM
Now, that does not mean that MANF will be denied orphan status, it just means that JN did not think that AMBS warranted inclusion in his article on orphan status, and he is one of the biggest AMBS backers.
Now, biotechs are BEST when anticipating news, and so while the orphan status indication is not going to come tomorrow, an anticipation by the market that it will come is great for those who want to be in the stock.
Regardless of the presence of that graph showing increased chances for eventual approval, I have more reservations that MANF will ever get to the clinic.
Some will say that means I am against MANF. That is not true, you never know until you test, and they will be testing MANF. Right now, that is where the value lies.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM